Background illustration for clinical trials search

Paid Clinical Trials Glendale

Discover 3,600 paid clinical trials in Glendale, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Investigate ALE.P02 as a Monotherapy or in Combination With Pembrolizumab in Adult Patients With Selected CLDN1+ Solid Tumors

for
Squamous Non-small-cell Lung Cancer,
Location: Los Angeles CA, Fullerton CA, Scottsdale AZ, Chicago IL,
Sponsor: Alentis Therapeutics AG

Sex: All

Age: 18+

Code: NCT06747585

Phase 1, Phase 2, Recruiting

A Study of VET3-TGI in Patients With Solid Tumors

for
Solid Tumor, Adult, Microsatellite Stable Colorectal Cancer,
Location: Los Angeles CA, Orange CA, Dallas TX, Houston TX,
Sponsor: KaliVir Immunotherapeutics

Sex: All

Age: 18+

Code: NCT06444815

Phase 1, Recruiting

Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas

for
Peripheral T-cell Lymphoma
Location: Los Angeles CA, Gilbert AZ, Dallas TX, Westwood KS,
Sponsor: CerRx, Inc.

Sex: All

Age: 18+

Code: NCT02495415

Phase 2, Recruiting

Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)

for
Colorectal Cancer Metastatic
Location: Los Angeles CA, Newport Beach CA, Atlanta GA
Sponsor: Buzzard Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06634875

Phase 2, Recruiting

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation,
Location: Los Angeles CA, Orange CA, La Jolla CA, Phoenix AZ,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05735184

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer

for
Metastatic Colorectal Adenocarcinoma,
Location: Los Angeles CA, Fullerton CA
Sponsor: University of Southern California

Sex: All

Age: 18+

Code: NCT06336902

Phase 1, Recruiting

Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Los Angeles CA, Aurora CO, Columbus OH, Orlando FL,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06233942

Phase 1, Recruiting

Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)

for
Extensive Stage Small Cell Lung Cancer
Location: Los Angeles CA, Seattle WA, Sioux Falls SD, Houston TX,
Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT06598306

Phase 1, Recruiting

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

for
Prostate Cancer,
Location: Los Angeles CA, Newport Beach CA, San Francisco CA,
Sponsor: Janux Therapeutics

Sex: Male

Age: 18 - 70+

Code: NCT05519449

Phase 1, Recruiting

A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)

for
Breast, Metastatic, Triple Negative, Cancer,
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 18 - 70+

Code: NCT04333706

Phase 1, Phase 2, Recruiting

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

for
Tumor Skin, Metastatic Melanoma, Melanoma, Lung Cancer,
Location: Los Angeles CA, Stanford CA, Tucson AZ, Houston TX,
Sponsor: Obsidian Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06060613

Phase 1, Phase 2, Recruiting

A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors

for
Triple Negative Locally Advanced Non-resectable Breast Cancer,
Location: Los Angeles CA, Vancouver, San Antonio TX, Nashville TN,
Sponsor: Marengo Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06827613

Phase 1, Phase 2, Recruiting

An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence

for
Head and Neck Carcinoma
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 18+

Code: NCT06420219

Recruiting

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

for
Head and Neck Squamous Cell Carcinoma
Location: Los Angeles CA, Duarte CA, Palo Alto CA, Santa Rosa CA,
Sponsor: Tempus AI

Sex: All

Age: 18+

Code: NCT06163534

Recruiting

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

for
Advanced Adenocarcinoma
Location: Los Angeles CA, Irvine CA, Seattle WA, Chicago IL,
Sponsor: BioAtla, Inc.

Sex: All

Age: 18+

Code: NCT05808634

Phase 1, Recruiting

A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.

for
Advanced Solid Tumors Cancer, MSI-H Cancer
Location: Los Angeles CA, Chicago IL, Louisville KY, Maumee OH,
Sponsor: Nimbus Wadjet, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06898450

Phase 1, Phase 2, Recruiting

Longitudinal Advanced Prostate Cancer Cohort (LAPCC)

for
Prostate Carcinoma
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: Male

Age: 18+

Code: NCT06067295

Recruiting

Access to Genetic Testing in Underserved Patients With Cancer

for
Breast Carcinoma, Male Breast Carcinoma,
Location: Los Angeles CA, Rochester NY
Sponsor: University of Southern California

Sex: All

Age: 18+

Code: NCT06422455

Recruiting

A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: Los Angeles CA, Orange CA, Aurora CO, Spokane WA,
Sponsor: Tvardi Therapeutics, Incorporated

Sex: All

Age: 18+

Code: NCT05440708

Phase 1, Phase 2, Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.

for
High-grade Serous Ovarian Carcinoma (HGSOC),
Location: Los Angeles CA, Vancouver, Toronto, Hackensack NJ,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06476808

Phase 1, Recruiting